OVERVIEW
The market size of tissue diagnostics is projected to reach USD 5.9 billion by 2024, increasing over the forecast period at a CAGR of 6.8 percent. The increasing incidence of cancer along with a rapidly aging population, technical advancements in tissue diagnostic techniques, and increased spending on health care are key drivers of market growth.
TABLE OF CONTENT
1 Global Tissue Diagnostics MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Tissue Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Tissue Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Tissue Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Tissue Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Tissue Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Tissue Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Consumables
8.2 Product
9 Global Tissue Diagnostics Market – By End User
9.1 Immunohistochemistry
9.2 In situ hybridization
9.3 Digital pathology and workflow management
9.4 Special staining
10 Global Tissue Diagnostics Market – By End User
10.1 Breast cancer
10.2 Gastric cancer
10.3 Lymphoma
10.4 Prostate cancer
10.5 Non-small cell lung cancer
10.6 Other
11 Global Tissue Diagnostics Market – By End User
11.1 Hospitals
11.2 Pharmaceutical companies
11.3 Research laboratories
11.4 Contract research organizations
11.5 Other
12 Global Tissue Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Tissue Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Tissue Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Roche
14.3 Danaher
14.4 Agilent Technologies
14.5 Thermo Fisher Scientific
14.6 Abcam
14.7 BD
14.8 Abbott
14.9 Merck
14.10 Sakura Finetek Japan
14.11 Qiagen
14.12 Company 11 & more
15 Global Tissue Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations